General AOD Knowledge
AOD & the Brain
Interventions
Motivational Interviewing
Harm Minimisation
100

This substance is the leading cause of preventable disease in Australia

Tobacco

100

A substance that mimics the actions of a neurotransmitter or hormone to produce a response

An agonist

100

It's the Recovery Star domain which discusses alcohol & other drug use

Addictive Behaviour

100

This intervention is a collaborative, goal-oriented style of communication with particular attention to the language of change.

Motivational Interviewing

100

This is the overarching principle of the current Australian National Drug Strategy

Harm minimisation

200

This substance is the most common drug of concern for which people received treatment

Alcohol

200

This neurotransmitter is responsible for reinforcing motivation & pleasurable experiences, & is a key driver in addiction

Dopamine

200

This medication reverses the effects of an opioid overdose, and is available for free over-the-counter

Naloxone

200

This is the foundation of motivational interviewing & has four elements:

- Partnership

- Acceptance

- Compassion

- Evocation

The Spirit of Motivational Interviewing

200

These are the three pillars of the harm minimisation approach

1. Harm reduction

2. Supply reduction

3. Demand reduction

300

This is the approximate percentage of people who experience co-occurring substance use disorders and mental illness

25%

300

Dysfunction in this part of the brain contributes to impulsive & compulsive substance seeking behaviours

Pre-frontal cortex

300

This is a type of psychosocial intervention, of less than 90min, which can be delivered opportunistically by a variety of clinicians and in a wide range of settings.

Brief Interventions

300

These are the four core skills of Motivational Interviewing

OARS

Open questions - Affirmations - Reflections - Summarisations

300

This pillar is described as reducing the adverse health, social and economic consequences of the use of AOD, using evidence-based strategies without judgement

Harm reduction

400

This is the life-threatening lung condition caused by vaping / e-cigarettes

E-cigarette or Vaping Associated Lung Injury (EVALI)

400

Negative feelings associated with withdrawal come from overactivation of the stress response in this part of the brain

Extended amygdala

400

This psychosocial intervention is aimed at identifying and challenging unhelpful thoughts, learning how these thoughts shape mood, and how together they impact behaviour. 

It has the best-documented efficacy of the psychosocial approaches for the treatment of people with harmful AOD use

Cognitive Behavioural Therapy

400

These are the four fundamental processes of Motivational Interviewing

Engaging - Focusing - Evoking - Planning

400

This pillar is described as preventing or delaying the use of AOD; reducing the misuse of AOD; and supporting people to recover from dependence through evidence-informed treatment

Demand reduction

500

Fill in the blanks from the DSM5-TR description of a Substance Use Disorder:

A cluster of BLANK, BLANK, and BLANK symptoms indicating that the individual continues using the substance despite significant substance-related problems.

Cognitive, Behavioural, and Physiological

500

This part of the brain becomes desensitised with repeated exposure to drugs, resulting in reduced feelings of pleasure from natural rewards

Basal ganglia

500

These are the guiding principles of AOD psychosocial interventions in NSW Health

(Name 3)

- Person-centred

- Trauma-informed

- Holistic

- Reducing harms / harm reduction

- Addressing stigma & discrimination

- NSW Clinical Care Standards for AOD Treatment

- Responsive to violence, abuse, & neglect

500

This framework can be used to respectfully share information with a consumer

Elicit-Provide-Elicit

Or the Recovery Star version:

Preface-Elicit-Permission-Provide-Elicit

500

Australia has adopted and promoted a harm minimisation approach since this year

1985

M
e
n
u